Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Life-threatening bacterial disease in humans explained
E.coli make up part of the normal gut flora of cattle and humans

Study suggests E. coli toxin in cattle responsible

A new study, published by scientists at the Moredun Research Institute, University of Edinburgh, Biomathematics and Statistics Scotland and international partners, has shown that a specific toxin produced by naturally-occurring E. coli bacteria help the organism to colonise the intestinal tract of cattle and increase transmission of the organism to other animals in the herd.

Rapid and high levels of expression of the toxin also mean that, when humans are infected, they are more likely to suffer more serious symptoms. These toxin properties help explain the emergence of this human pathogen over the last 40 years.

Escherichia coli (E. coli) is a group of bacteria that make up part of the natural gut flora of healthy humans and some animals. While many strains are harmless, some are known to cause serious disease.

Enterohaemorrhagic E. coli (EHEC) O157 are a subset of E. coli that are present in the gastrointestinal tract of cattle but cause no discernible disease in these animals. However, EHEC O157 excreted in the faeces of infected cattle, can be passed on to humans through exposure to contaminated water, meat or vegetables.

EHEC produce toxins known as Shiga toxins (Stx) of various sub-types. These toxins can cause a variety of diseases in humans by attacking the lining of blood vessels within the body. Clinical signs range from diarrhoea – with or without blood – to more severe and potentially fatal kidney disease. The most dangerous toxin subtype to humans is subtype 2a (Stx2a).

The study investigated the role of Stx2a in colonisation of the cattle gut. It showed that Stx2a plays a critical role in increasing transmission of EHEC O157 between cattle owing to a combination of two factors

  • firstly, Stx2a is produced more rapidly by the bacteria than other Shiga toxins;
  • secondly, Stx2a promotes persistence of the bacteria on cells which line the gastro-intestinal tract of cattle by reducing their turnover rate.

This essentially allows infected cells to survive for longer.; and makes it more likely that the cattle will shed the bacteria in their faeces for longer and at higher levels – thereby increasing the chance that the bacteria can be passed to other cattle in the herd as well as to humans.

Prof David Gally, from the Roslin Institute said: “The study is important as it explains firstly why the Stx2a subtype has become common in E. coli O157 strains – the answer being that it can be produced more rapidly compared to some other Stx subtypes.

“Secondly, our work demonstrates how the toxin can provide an advantage in the animal host, basically by halting the usual turnover of gut cells that would remove adherent E. coli; so the bacteria colonise more easily, persist in the gut and can be excreted at high levels to go onto infect other animals and, possibly, humans”.

The original study was funded by the Food Standards Agency and Food Standards Scotland; and ongoing work between the study partners has developed a vaccine for use in cattle which has recently obtained commercial backing for a field trial.

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.